Few Adolescents With Obesity Prescribed Obesity Medications

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 13, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 13, 2025 -- Despite an increase in the prevalence of prescribing, only 0.5 percent of U.S. adolescents with obesity were prescribed an obesity medication in 2023, according to research published in the June 5 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Using ambulatory electronic medical record data, Lyudmyla Kompaniyets, Ph.D., from the CDC in Atlanta, and colleagues examined trends in the proportion of U.S. adolescents aged 12 to 17 years with obesity who were prescribed U.S. Food and Drug Administration-approved obesity medications during 2018 to 2023.

The researchers observed a substantial increase in the proportion of U.S. adolescents who were prescribed obesity medication in 2023 (by about 300 percent compared with 2020), the year after expansion of FDA approval of two obesity medications to include adolescents. In 2023, 0.5 percent of adolescents with obesity were prescribed an obesity medication, with 83 percent of prescriptions being received by adolescents with severe obesity. The most commonly prescribed medications were semaglutide, followed by phentermine or phentermine-topiramate. Higher prevalence of prescribing was seen among girls than boys (adjusted prevalence ratio [aPR], 2.05), adolescents aged 15 to 17 versus 12 to 14 years (aPR, 2.24), and among those with class 2 or 3 versus class 1 obesity (aPRs, 4.03 and 12.78, respectively). Lower prescribing prevalence was seen for Black or African American adolescents versus White adolescents (aPR, 0.61).

"The findings in this report indicate that health care providers tended to prescribe obesity medications to adolescents with severe obesity," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-14 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords